HomeTagsREGENXBIO

REGENXBIO

Biotechnology

REGENXBIO Opens State-of-the-Art Gene Therapy Manufacturing Facility

PR Newswire - June 13, 2022

REGENXBIO Inc. is celebrating the opening of its new Manufacturing Innovation Center gene therapy manufacturing facility. Also Read: Updated Data for Janssen’s Bispecific Teclistamab Suggest...

Biotechnology

REGENXBIO Presents Positive Interim Data from Phase II ALTITUDE Trial of RGX-314

PR Newswire - February 14, 2022

REGENXBIO Inc. announced additional positive interim data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without...